We invest in what we know and what we believe. We know that there are talented people with disruptive ideas in markets and geographies where we spend our time. We believe that emerging companies require the support of a community of like-minded individuals and institutions to create the next generation of technologies.
Managing Director and Co-founder
Jesse leverages his hands-on operating experience and industry contacts to lead our efforts in the Built Environment.
Jesse leverages his hands-on operating experience and industry contacts to source and nurture innovative companies applying technology to design, build, and improve our world. He currently manages the firm’s involvement with Builtr Labs, Helix.RE, and courbanize. Previously, he led Borealis’ investments in Envista Software (acquired by Accela), Handmark (acquired by Sprint), IrisMaps (acquired by OmniEarth), Scribe Software (acquired by The Mustang Group), SketchUp (acquired by Google), SpaceClaim (acquired by ANSYS), TinkerCad (acquired by Autodesk), VICO Software (acquired by Trimble), and Newforma (acquired by Battery Ventures).
Prior to co-founding Borealis Ventures, Jesse served as an executive in two public application software companies. He helped grow Softdesk from a New Hampshire start-up to a multinational public company and played an integral role in the sale of the business to Autodesk. While at Autodesk, Jesse led the integration of the two companies and served on the Autodesk executive staff as the Vice President and General Manager of the Architecture, Engineering, and Construction Division.
Jesse recently concluded his service as a member of the Board of Directors of the New Hampshire Charitable Foundation and has served on numerous other non-profit boards. He graduated with Distinction from the Indiana University School of Public and Environmental Affairs and completed his military service as a member of the White House Communications Agency.
Managing Director and Co-founder
Phil draws on his experience in commercializing translational research to help entrepreneurs build life science and digital health companies.
Phil leads the firm’s healthcare investing, leveraging his 20 years of experience advancing Dartmouth College’s innovation ecosystem. He currently leads Borealis’ investments in Adimab, Avedro, Avitide, Compass Therapeutics, Evox Therapeutics, Orbit Discovery and Vets First Choice. Phil also led the firm’s prior investments in GlycoFi (acquired by Merck & Co.) and M2S (acquired by AIG Altaris Health Partners).
Phil joined Borealis from Dartmouth College’s Tuck School of Business, where he was the founding Executive Director of the Center for Private Equity and Entrepreneurship. Phil remains an adjunct member of Tuck’s faculty teaching venture capital and entrepreneurship topics. Phil was previously a trustee of the Dartmouth Regional Technology Center.
Prior to joining the Tuck faculty, Phil held senior strategy and business development roles at a privately-held application software company. Earlier in private legal practice, he counseled technology startups, Fortune 500 companies and foreign governments on sensitive trade, tax, and investment matters.
Phil received an A.B. degree from Dartmouth College, a J.D. from the University of Virginia School of Law and a M.B.A. (with High Distinction) from the Tuck School of Business at Dartmouth.
Matt combines the insights gained from a decade building Internet companies in Silicon Valley with more than ten years serving as an investor in emerging technology companies in and around New Hampshire.
Matt uses the contacts and insights he gained from a decade of building companies in Silicon Valley to lead Borealis investments in a range of software companies. He currently directs the firm’s investments in Honest Buildings, Builtr Labs, and SketchFab. He previously led Borealis’ involvement with DYN (acquired by Oracle), Flurry (acquired by Yahoo), Fieldlens (acquired by WeWork), OmniEarth (acquired by EagleView Technologies), Wingu (acquired by Perkin Elmer), and Handmark (acquired by Sprint). Matt joined Borealis full-time in 2005 after serving as an advisor to the firm from its inception.
Prior to joining Borealis, Matt was the COO of Efficient Frontier, a venture-funded marketing services company that applies portfolio optimization techniques from financial markets to the marketplace of online advertising. The company was acquired by Adobe in 2012. Matt began his Internet career as an early member of the team at Yahoo!, which he joined in 1995 when the company was pre-revenue.
Matt is a past member of the Board of Directors for Grassroot Soccer, a non-profit leading the effort to educate youth in Africa about adolescent health. He has also served on the Board of the Children’s Literacy Foundation (CliF), which aims to inspire reading and writing among at-risk youth in New Hampshire and Vermont. Matt has also chaired both the Entrepreneur’s Foundation of New Hampshire and AlphaLoft, an accelerator for emerging entrepreneurs in New Hampshire.
Matt earned his M.B.A. from the Tuck School of Business at Dartmouth College (where he is a past member of the MBA Council) and also received his B.S. in Industrial Engineering from Stanford University.
Emily supports deal flow and provides oversight to various companies in the firm’s healthcare portfolio, having spent her early career in healthcare venture capital for a Boston firm.
Emily joined Borealis in 2017 to support the firm’s investment in life sciences and digital health.
Emily holds a biology degree from the University of Louisville, magna cum laude, and most recently graduated as a Tuck Scholar with an MBA from the Tuck School of Business at Dartmouth College. While at Tuck, Emily served as Managing Director for the Tuck/DEN Venture Fund, where she advised local entrepreneurs and Dartmouth affiliated startups.
Adam focuses on diligence and portfolio support in life sciences, having research experience in Psychology and Neurology.
Adam holds a BS degree in Neuroscience and Immunology from Brown University and an MS in Biotechnology from Johns Hopkins. He is currently pursuing a PhD in Cognitive Neuroscience from Dartmouth College, with his research focusing on the neural basis of decision making and habits.
Katharine von Herrmann
Katharine focuses on diligence and portfolio support in life sciences, having research experience in molecular biology and managed partnership projects for a disease focused foundation.
Katharine holds a BA degree in Biochemistry and an MS degree in Biological Sciences from Smith College. She previously worked at the Spinal Muscular Atrophy Foundation supporting preclinical and clinical development of therapeutics for SMA patients. Katharine is currently pursuing a PhD in Experimental and Molecular Medicine from the Guarini School of Graduate and Advanced Studies at Dartmouth, with her research focused on characterizing the molecular mechanisms of Parkinson’s disease-associated neuroinflammation.
Dave focuses on deal sourcing and diligence in the digital health space, having consulted companies in the early stages.
Dave holds a chemical engineering degree from Northwestern University, cum laude, and recently graduated with an MBA from the Tuck School of Business at Dartmouth College where he is also
enrolled in the MD program at Geisel School of Medicine. At Tuck, Dave was a Director of the Tuck Social Venture Fund, where he sourced and led diligence on companies in the digital health space. He has also worked and consulted for digital health and healthcare service companies spanning pre-revenue to growth stage.
“Jesse’s understanding of the marketplace and network of knowledgeable influencers in it provided tremendous leverage to NewForma as it blossomed from idea to product to business. In my view, only a few investors possess personal experience on the operating side of the table and deploy that experience so effectively for the benefit of the founders and management team with whom they work.”
Ian Howell, CEONewForma
“One of the biggest challenges any CEO faces is anticipating what lies around the next bend in the journey. Phil’s experience alongside a decades worth of early life sciences entrepreneurs and frequent hands-on mentoring has proven invaluable to Avitide as we’ve charted our course.”
Kevin Isett, CEO and founder
“Without the capital and start-up expertise provided by the Borealis team, the path we charted from idea to market leader would certainly have been less direct, taken more time, AND consumed much more resources. They’ve been a true partner throughout.”
Ben Shaw, CEO and founder
Vets First Choice
We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.